Autonomix Medical
Marco Bedoya is currently the Director of Product Development at Autonomix Medical, after holding various engineering positions at companies such as Wright Medical Technology, Hologic, and Abiomed. Marco has a strong background in mechanical and electrical engineering, with a focus on product development and support for manufacturing processes. With a Master's degree in Electrical and Electronics Engineering from Tecnológico de Costa Rica, Marco has a solid foundation in engineering education to support their career growth in the medical technology industry.
This person is not in any teams
Autonomix Medical
Autonomix (Nasdaq: AMIX) is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. We are initially developing our technology for pancreatic cancer pain, a condition that can cause debilitating pain and needs an effective solution. However, our technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum.